RARE CANCER RESEARCH FOUNDATION
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$1,773,373
Contributions
67%
Program Services
31%
Investments
3%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Other
0%
Expenses in 2024
$2,240,471
Salaries & Benefits
54%
Fees to Service Providers
32%
Offices, Occupancy & IT
4%
Grants
4%
Advertising & Promotion
3%
Other
3%
Benefits to Members
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$2,606,409
$1,184,545
-55%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$891,959
$541,563
-39%
Membership Dues
$0
$0
-
Investments
$0
$47,265
-
Other
$5,592
$0
-100%
Total Revenues
$3,503,960
$1,773,373
-49%
Expenses
2023
2024
Change
Grants
$0
$81,890
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$1,039,281
$1,204,406
+16%
Fees to Service Providers
$464,393
$719,116
+55%
Advertising & Promotion
$13,515
$71,474
+429%
Offices, Occupancy & IT
$72,917
$99,398
+36%
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$577,513
$64,187
-89%
Total Expenses
$2,167,619
$2,240,471
+3%
Net income
2023
2024
Change
Net income
+$1,336,341
-$467,098
-135%
Functional Expenses
Summary
2023
2024
Change
Program
$1,527,627
$1,647,416
+8%
Admin
$639,992
$446,491
-30%
Fundraising
$0
$146,564
-
Total Expenses
$2,167,619
$2,240,471
+3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)